Bivalent vaccination against COVID-19 can trigger a humoral response in immunocompromised patients who receive monoclonal antibody prophylaxis

J Nephrol. 2023 Jul;36(6):1719-1721. doi: 10.1007/s40620-023-01699-5. Epub 2023 Jul 6.

Authors

Pierre Housset¹, Christine Bouhelier², Agathe Pardon², Latifa Hanafi², Nathalie Vittoz², Dogan-Firat Bozman², Wassila Amar², Valérie Caudwell², Thibaut Charlemagne²

Affiliations

¹ Department of Nephrology, Centre Hospitalier Sud-Francilien, 40 Avenue Serge Dassault, 91100, Corbeil-Essonnes, France. pierre.housset@chsf.fr.
² Department of Nephrology, Centre Hospitalier Sud-Francilien, 40 Avenue Serge Dassault, 91100, Corbeil-Essonnes, France.

PMID: 37410357
DOI: 10.1007/s40620-023-01699-5

No abstract available

Keywords: COVID-19; Humoral response; Immunosuppression; Monoclonal antibody; SARS-CoV-2; Transplantation; mRNA vaccine.

Publication types

Letter

MeSH terms

COVID-19* / prevention & control
Humans
Immunity, Humoral
Immunocompromised Host